Tirzepatide is FDA-approved for: Individuals with a body mass index of 30 (or 27 with weight-related conditions such as, type 2 diabetes mellitus, or metabolic resistance) Women managing Polycystic Ovary Syndrome (PCOS) Those with prediabetes or insulin resistance Anyone whos struggled with weight despite consistent efforts and is ready for a more targeted, science-backed solution If youre unsure whether you qualify, a simple consultation with a qualified provider can help determine if Tirzepatide aligns with your health goals
So, if you do take it, please take it for the disease of obesity, he pleads
People drink more slowly, and the whole experience becomes less pleasurable
Dietary modifications can substantially improve tolerability
Abdominal pain or discomfort is frequently reported and may manifest as cramping, bloating, or generalized abdominal discomfort